大会上，中国工程院院士、中国抗癌协会理事长樊代明，中国中医科学院学部委员、国医大师唐祖宣，中国中医科学院研究员于智敏等多位专家 分别围绕《中药产业发展之我见》《传统名医、传统名方（验方）对山参的应用》《中医视域下的山参解读》等课题进行专题报告。与会专家还 就山参产业高质量发展的新路径，如何促进山参产业链整合、价值链提升、市场链优化等问题进行了深入探讨。 新华网沈阳9月28日电 以"做强核心产区优势，助力建设健康中国"为主题的"2025山参产业高质量发展大会暨桓仁山参健康中国行"活动近日在上 海举行。大会特邀中国中药协会领导、中国工程院院士、国医大师、专家、国内企业家代表300余人参加，共议中国山参产业高质量发展机遇， 共绘山参中医药产业发展美好蓝图。 桓仁是中国林下山参的核心产区，保护地面积65万亩，产品占全国市场份额的70%以上，无论从基地规模、产量及品质均居全国之首，被授 予"中国山参之乡""中国山参名县"称号。桓仁山参产业已形成集种植、加工、科研、检测、销售、品牌、文化"七位一体"的产业集群，以"桓仁 山参"为主导的中医药健康产业集聚效应凸显，成为辽宁省中医药产业先导示范区和中国山参产业发展的引领者。 ...

Core Viewpoint - The 15th Yulin Traditional Chinese Medicine Expo is being held in Yulin, Guangxi, attracting businesses to explore opportunities in the "Southern Medicine Capital" [1][3]. Group 1: Event Overview - The expo features a professional exhibition area of 70,000 square meters, showcasing renowned pharmaceutical companies, quality medicinal materials, advanced medical devices, and health products from across China [1]. - Concurrently, the 2025 Yulin Traditional Chinese Medicine Health Industry Investment Promotion Conference took place, resulting in the signing of 12 projects, including the deep processing of agarwood and an online trading platform for medicinal materials [1][3]. Group 2: Industry Significance - Yulin is a major production area for medicinal materials in Guangxi, hosting China's third-largest professional market for traditional Chinese medicine, with over 3,000 varieties and an annual transaction volume of 12 billion RMB [1]. - The city is recognized as "Southern Fragrance Capital," featuring the largest and most diverse international spice market in China [1]. Group 3: Future Development - Yulin is actively building an open platform connecting ASEAN and the global market, aiming to create a national-level health industry hub that integrates planting, processing, research, trading, exhibitions, and wellness [5]. - The Yulin Traditional Chinese Medicine Health Industry Park covers an area of 24 square kilometers and has attracted 98 enterprises, including well-known pharmaceutical companies [3].